Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Rewiring the Chronic Pain Experience: Single-Session Model of Pain Reprocessing Therapy (PRT) at The Ottawa Hospital

30 de outubro de 2026 atualizado por: Ottawa Hospital Research Institute

Rewiring the Chronic Pain Experience: Feasibility and Pilot Testing of a Single-Session, 4-Hour Delivery Model of Pain Reprocessing Therapy (PRT) at The Ottawa Hospital (TOH)

The goal of this study is to find out if a one-time session of Pain Reprocessing Therapy (PRT) intervention improves participant's mood and pain. Participants in this 4 hours session will be 40 patients who've been referred to the The Ottawa Hospital Pain Clinic (TOHPC) for chronic pain.

The main questions of this study are:

  • Can we recruit 40 participants within 6 months?
  • Do at least 32 participants complete the session and answer follow up questions?
  • Does 1 session of PRT have a positive impact on participants' mood and pain?

Participants in this study will:

  • Attend 1 session of PRT.
  • Answer questions that relate to their experience of pain and their mood. They will answer these questions immediately before/after the session, 1 week after the session, and 1 month after the session.
  • After the session, some participants will participate in an interview to talk about their experience.

Visão geral do estudo

Status

Recrutamento

Condições

Tipo de estudo

Intervencional

Inscrição (Estimado)

40

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

  • Nome: Susan Ward, MSW
  • Número de telefone: 72123 613-737-8899
  • E-mail: SWard@toh.ca

Estude backup de contato

  • Nome: Research Co-ordinator
  • Número de telefone: 73903 6137378899
  • E-mail: painresearch@toh.ca

Locais de estudo

    • Ontario
      • Ottawa, Ontario, Canadá, K1H8L6
        • Recrutamento
        • The Ottawa Hospital
        • Investigador principal:
          • Susan Ward, MSW

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Minimum age of 18 years or older at time of consent.

  • Chronic pain persisting for a minimum of 3 months, consistent with the International Association for the Study of Pain (IASP) definition of chronic pain.

  • Self-reported 1-week average pain intensity score between 4/10 and 9/10 on the Brief Pain Inventory (BPI)12 at screening.

    o Note: Individuals scoring less than 4/10 or more than 9/10 will be directed to other pain clinic workshops and available resources (e.g., Power Over Pain)

  • Referred to TOHPC and triaged by a registered nurse, nurse practitioner, or physician to the "diffuse pain" pathway;

  • Completed the initial pain clinic patient education and resource session (PERS) for patients triaged to the "diffuse pain" pathway;

  • Currently waiting for a 1st consultation with the Nurse Practitioner assigned to the "diffuse pain" pathway.

  • Able to read, write, and communicate in English at a level sufficient to engage with research team, the psychoeducational content, and to complete self-report measures.

  • Able to attend a single, in-person 4-hour group session at TOHPC in Ottawa on a scheduled weekday.

Exclusion Criteria:

  • Active mental health symptoms that significantly interfere with the ability to engage with psychoeducational content (e.g., dissociation, active psychosis), or participate in a group setting
  • Cognitive impairment that significantly limits the ability to comprehend study information, provide informed consent, or meaningfully engage with psychoeducational content.
  • Scheduled for a major surgical procedure within the study timeframe.
  • Currently receiving other individual or group psychotherapy that directly targets pain, pain cognitions, or pain-related emotional responses within the 12 weeks prior to enrollment.
  • Currently receiving interventional pain management services (e.g., injections, nerve blocks) from another clinic or institution within the 12-week period prior to enrollment through the 3-month follow-up.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: N / D
  • Modelo Intervencional: Atribuição de grupo único
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Pain Reprocessing Therapy (PRT) session

The intervention involves a single 4-hour PRT in-person group session (up to 20 patients per group) at The Ottawa Hospital Pain Clinic, delivered by a PRT certified clinician.

The intervention is a brief mindfulness exercise (mindfulness of breath, energy, emotions, thoughts, sensations), followed by 90 minutes of didactic content focused on pain science education and foundation of pain reprocessing therapy. This includes interactive discussions, self-reflection, and skills building. This is followed by a brief exercise called predictive coding where participants are invited to draw a picture representing their pain. The remainder of the session includes gentle movement, somatic tracking, and practices to increase positive affect induction- specifically leaning into positive or neutral sensations and establishing short-term safety behaviours.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Clinical Effectiveness: Brief Pain Inventory (BPI) Pain Intensity and Pain Interference
Prazo: Baseline, 1 week post-intervention, 1 month follow up.

Clinical effectiveness outcome measurement tools include Brief Pain Inventory (BPI): Participants will localize their pain through a drop down menu, in which they will select the applicable body part(s) where they experience pain. The BPI Pain Intensity and Pain Interference scales will then be administered. The pain intensity subscale includes 4 pain intensity ratings using an 11-point numerical rating scale (0-10) on current pain, average pain, worst pain during the last 7 days and least pain during the last 24 hours. The pain interference subscale includes 7 interference items that ask the patient to respond using an 11-point numerical rating scale (0-10). These items include the effect on general activity, mood, walking ability, normal work (including housework), relations with other people, sleep, and enjoyment of life.

Baseline, 1 week post-intervention, 1 month follow up.
Interview
Prazo: Interviews will be conducted within 6 months of participating in the PRT session.

A random selection of participants will be interviewed regarding their PRT experience.

Interviews will be conducted within 6 months of participating in the PRT session.
Clinical Effectiveness: Pain Self-Efficacy Questionnaire (PSEQ-10)
Prazo: Baseline, 1 week post-intervention, 1 month follow up.

Clinical effectiveness outcome measurement tools include Pain Self-Efficacy Questionnaire (PSEQ-10): The PSEQ-10 is a validated 10-item tool for assessing the patient's pain self-efficacy or belief in one's capability to perform activities even when undergoing pain. The 10 items ask the patient to rate their confidence in doing activities on a 7-point numerical rating scale (0-6), with higher scores indicating greater confidence.

Baseline, 1 week post-intervention, 1 month follow up.
Clinical Effectiveness: Patients' Global Impression of Change (PGI-C) Scale
Prazo: 1 week post-intervention, 1 month follow up.

Clinical effectiveness outcome measurement tools include Patients' Global Impression of Change (PGI-C) Scale: The PGI-C is a validated single- item self-report measure used to assess a patient's perceived change in overall status following a treatment or intervention. Patients select one of 7 options to describe their experience, ranging from "very much worse" to "very much improved." The PGI-C is widely used in chronic pain research and has demonstrated sensitivity to clinically meaningful change across a range of pain populations.

1 week post-intervention, 1 month follow up.
Clinical Effectiveness: Positive and Negative Affect Scale (PANAS)
Prazo: Day of Intervention, 1 week post-intervention, 1 month follow up.

Clinical effectiveness outcome measurement tools include Positive and Negative Affect Scale (PANAS) PANAS is a validated 20-item self-report measure assessing two distinct dimensions of mood: positive affect and negative affect. Participants rate the extent to which they have experienced each emotion using a 5-point Likert scale (1 = very slightly or not at all, 5 = extremely), with higher positive affect scores and lower negative affect scores reflecting better emotional well-being. The PANAS has demonstrated strong reliability and validity across clinical populations, including individuals with chronic pain.

Day of Intervention, 1 week post-intervention, 1 month follow up.

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Feasibility of recruitment
Prazo: Baseline

• Rates of participant eligibility and consenting will be tracked

o The single session PRT model will be considered feasible if we can recruit our target sample size of 40 participants over a 6-month period.

Baseline
Rate of participant accrual/completion
Prazo: Baseline, Day 7, and Day 30

• Rates of participant accrual, screening, and 1-week and 1-month assessment completion will be tracked

o The evaluation procedures will be considered feasible if we retain more than 80% of participants at 1-month follow-up.

Baseline, Day 7, and Day 30

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: Susan Ward, MSW, The Ottawa Hospital

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

16 de outubro de 2026

Conclusão Primária (Estimado)

1 de maio de 2027

Conclusão do estudo (Estimado)

1 de outubro de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

14 de outubro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

30 de outubro de 2026

Primeira postagem (Real)

5 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

5 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

30 de outubro de 2026

Última verificação

1 de outubro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever